Cargando…
Doses of Insulin and Its Analogues and Cancer Occurrence in Insulin-Treated Type 2 Diabetic Patients
OBJECTIVE: Recent epidemiological studies suggested that some insulin analogues could be associated with increased risk of cancer. The present study is aimed at assessing the long-term association of different insulin analogues with cancer incidence. RESEARCH DESIGN AND METHODS: A nested case-contro...
Autores principales: | Mannucci, Edoardo, Monami, Matteo, Balzi, Daniela, Cresci, Barbara, Pala, Laura, Melani, Cecilia, Lamanna, Caterina, Bracali, Ilaria, Bigiarini, Michela, Barchielli, Alessandro, Marchionni, Niccol̀o, Rotella, Carlo Maria |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2928350/ https://www.ncbi.nlm.nih.gov/pubmed/20551014 http://dx.doi.org/10.2337/dc10-0476 |
Ejemplares similares
-
Metformin and Cancer Occurrence in Insulin-Treated Type 2 Diabetic Patients
por: Monami, Matteo, et al.
Publicado: (2011) -
Rosiglitazone and Risk of Cancer: A meta-analysis of randomized clinical trials
por: Monami, Matteo, et al.
Publicado: (2008) -
Effects of Glucagon-Like Peptide-1 Receptor Agonists on Body Weight: A Meta-Analysis
por: Monami, Matteo, et al.
Publicado: (2012) -
False and true pre-treatment predictors of weight loss in obese patients starting a program for lifestyle change
por: Cresci, Barbara, et al.
Publicado: (2014) -
Psychopathology and Continuous Subcutaneous Insulin Infusion in Type 1 Diabetes
por: Rotella, Francesco, et al.
Publicado: (2013)